lntroditction
The production of a functional protein does not end with the termination of the growing polypeptide chain. This, while clearly true of all proteins, is particularly obvious in the case of secretory proteins. While all proteins must fold to a functional conformation, and many must assemble into some supramolecular structure, secretory proteins must also make their way across membranes and through secretory compartments. In the course of this secretory pathway, most proteins undergo further chemical modification, so that the covalent structure of the ultimate functional protein is significantly different from that of the initial translation product. Some of these post-translational chemical modifications are ubiquitous in secretory proteins. Thus (with a single known exception, ovalbumin) all secretory proteins undergo cleavage of an N-terminal secretory signal sequence, and in most cases the Cys residues of the initial translation product are paired and oxidized to form disulphide bonds; glycosylation of asparagine, serine and threonine side-chains, and subsequent processing of oligosaccharide side-chains, leads to formation of very complex N-and 0-linked oligosaccharide structures in the majority of secretory and cell-surface proteins. Other modifications are limited to small families of proteins.
Selective proteolysis is a common post-translational modification, which does not generate novel amino acid derivatives. Apart from the cotranslational cleavage of the N-terminal secretory signal sequence (Hortsch & Meyer, 1986) , secretory proteins often undergo proteolysis at a late stage before secretion, either by endoproteolytic cleavage specifically at paired basic residues (Geisow & Smyth, 1980) or through stepwise removal of N-terminal dipeptides (Kreil et al., 1980) . These processes are observed in insects and yeast as well as vertebrates (Kreil, 1985) .
Some modifications act not on amino-acyl side-chains, but on the N-and C-terminal amino and carboxyl groups. Many polypeptides are N-terminally acylated, either by acetyl-or fatty acyl groups. N-Terminal acetylation is quite common and is known to be a cotranslational process occurring on nascent chains of 20-50 residues; it is generally found in intracellular proteins, but is also observed in ovalbumin and membrane proteins which lack the cleavable N-terminal signal sequence (Tsunasawa & Sakiyama, 1984) . N-Terminal palmitylation is observed in some bacterial membrane proteins, and N-terminal myristylation in a small number of intracellular eukaryotic proteins (Aitken & Cohen, 1984; Henderson el at., 1983) . A C-terminal amide group is found in a large number of neuropeptides and other small peptide hormones, and this is now known to be formed from a Cterminal Gly which is removed in the reaction Xaa-CO-NH-CH,COO--Xaa-CO-NH,. Frequently, but not universally, the C-terminal Gly is itself the product of previous proteoAbbreviations used: ER, endoplasmic reticulum; PDI, protein disulphide-isomerase; PAPS, 3'-phosphoadenosine 5'-phosphosulphate. lytic cleavage at paired basic residues, so that the sequence Xaa-Gly-Arg/Lys-Arg/Lys-Yaa in a translated cDNA sequence is predictive of a C-terminally amidated peptide (Kreil, 1985) .
Side-chain modifcations characteristic of secreted proteins
Approximately 150 derivatives of the 20 genetically coded amino acids have been identified as products of posttranslational modification (Uy & Wold, 1977; Wold, 1981) . Many of the processes involved here have been reviewed in recent volumes (Freedman & Hawkins, 1980 Wold & Moldave, 1984a, b) . Certain side-chain modifications are highly characteristic of secretory proteins, and this review will concentrate on a small number of these modifications. N-Glycosylation is too complex and ubiquitous a modification to be summarized here, but some brief comments will be made on each of the other modifications given in Table 1 .
Disulphide bonds are found in almost every class of extracellular protein secreted by higher eukaryotes and the formation of these bonds occurs within the lumen of the endoplasmic reticulum (ER); in the case of multidomain proteins, such as immunoglobulins and serum albumin, there is evidence that disulphide bonds form cotranslationally in that those in N-terminal domains form before the more Cterminal domains have been completely translated. The source of oxidizing equivalents is not established, but work in vitro suggests that it is not oxidation per se which is ratedetermining, but isomerization of disulphides to form the set which is compatible with folding to the most stable conformation. The catalyst of this process is protein disulphideisomerase (PDI), an abundant enzyme in the ER of secretory cells. PDI is a soluble, heat-stable, acidic, homodimeric (2 x 57 000) protein containing two putative active sites per polypeptide, each containing a local dithiol in the sequence Lee & Huttner (1985 Vol. 17
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Trp-Cys-Gly-His-Cys-Lys. It is the only one of the enzymes to be discussed in this paper to have been cloned and completely sequenced. It is not clear whether PDI is freely soluble in the ER lumen or peripherally bound to the luminal surface of the ER membrane, but its C-terminal sequence -Lys-Asp-Glu-Leu, has been proposed to be a signal effecting retention of soluble proteins within the lumen. Carboxylation of glutamyl residues to give the y-carboxyGlu side-chain (-CH,-CH(COOH),,Gla) was initially discovered in prothrombin and other liver-derived proteins of the blood-clotting system. It is now known in extracellular proteins with other functions secreted by a wider range of cell types, but it is clearly a specialist modification which confers the special property of high Ca2+-affinity through the generation of vicinal dicarboxylate groups. In the bloodclotting system, this brings about the concentration of clotting factors on phospholipid surfaces. The carboxylation reaction requires a reduced vitamin K derivative as cofactor:
Glu + KH, + CO, + 0, -Gla + KO + H 2 0 and the recycling of the epoxide (KO-K-KH,) requires a dithiol reductant, either dithiothreitol or thioredoxin, which may be the physiological reductant (van Haarlem et al., 1987) . These recycling steps are inhibited by warfarin and other coumarin anticoagulants. y-Carboxylation of Glu residues occurs on nascent secretory proteins within the ER and the vitamin K-dependent y-carboxylase system is an integral protein of the ER membrane; it has not, to date, been solubilized and purified in an active form and there is little information about the enzyme protein.
Hydroxylation of Pro and Lys residues is another modification known to occur on nascent secretory polypeptides and is characteristic, in animal cells, of collagens and proteins containing regions of collagen-like triple helical conformation. Three distinct enzymes are involved, specific for lysyl hydroxylation, prolyl-3-hydroxylation and prolyl-4-hydroxylation; of these, the last has been characterized in greatest detail. The reactions of all the enzymes are kinetically and mechanistically similar, involving 0, and a-ketoglutarate as cosubstrates (substrate -H + 0, + HOOC-CH,
Both FeL+ and ascorbate are required, and the evidence is that Fez+ is an obligatory cofactor which undergoes oxidation/reduction during each catalytic turnover, whereas ascorbate is required non-stoichiometrically to reverse an autoxidation of the enzyme which occurs spontaneously approximately once in 10-50 turnovers. Hydroxylation is required to stabilize the intermolecular interactions in the collagen triple helix, and in underhydroxylated collagen (such as is produced in cases of ascorbate-deficiency or on treatment of cells or tissues with Fe2+ chelators), the triple-helical conformation is only stable below physiological temperatures. The hydroxylases are located within the ER lumen associated with the membrane, but can be solubilized and purified. Lysyl hydroxylase is a homodimer (2 x 80 000), whereas prolyl-4-hydroxylase is an a2P2 tetramer (2 x 64 000 + 2 x 57 000). Recently, the remarkable discovery was made that the B-subunits of this enzyme are identical to protein disulphide-isomerase (Pihlajaniemi et al., 1987; Koivu et al., 1987) . In most tissues, the free PDI dimer is in great excess over the prolyl-4-hydroxylase tetramer, but in tendon, the amounts in the two states are comparable. The a-subunit of prolyl-4-hydroxylase is known to form the binding sites for peptide substrate and a-ketoglutarate, but both may be implicated in the interaction with ascorbate. Both the lysyl hydroxylase subunit and the a-subunit of prolyl-4-hydroxylase undergo Nglycosylation to give various high-mannose conjugates.
Sulphation of tyrosyl residues is a modification which has only recently begun to be investigated systematically, and it is too soon to know how widespread it may be. Unlike the 'early' modifications discussed above, tyrosine 0-sulphation appears to occur within the Golgi and an enzyme has been located there capable of transferring sulphate from PAPS to an acidic Tyr-containing random polypeptide substrate. Sulphated tyrosyl residues have been found in a number of hormonally active polypeptides, and also in the egg-yolk protein vitellogenin in Drosophila. Tyrosyl 0-sulphation appears to be confined to secretory proteins, but its physiological significance remains unclear.
Specificity of post-translational modification
The specificity of post-translational modifications is a difficult topic, but one of central importance (see the Introduction). In some cases, local primary structure features are necessary, but not sufficient for specifying modification. Thus N-glycosylation in animal cells is restricted to Asn residues in the sequence Asn-Xaa-Ser/Thr, and this specificity is observed across a wide taxonomic range; while yeast proteins are exclusively glycosylated at Asn-Xaa-T hr sites, a recombinant mammalian protein (human granulocyte macrophage-colony stimulating factor) is authentically glycosylated at an Asn-Xaa-Ser sequence when expressed in yeast (Ernst et al., 1987) . Only one third of Asn-XaaSer/Thr sites in secretory proteins are actually glycosylated, and in many proteins glycosylation at a given site is substoichiometric. The local specificity feature for prolyl-4-hydroxylation is Xaa-Pro-Gly, but in repeating (Xaa-ProGly),, polypeptides, there is a strong preference for (Pro-Pro-Gly ),,, and in comparison between Pro-Pro-Gly repeats of various lengths, there is a 400-fold decrease in K, in going from the simple tripeptide to (Pro-Pro-Gly),,,; the K, for the natural substrate is 250-fold lower still.
No reproducible local specificity feature around Glu is identifiable in sites which undergo y-carboxylation. The small peptide Phe-Leu-Glu-Glu-Leu (FLEEL) is widely used as a model substrate; it has a K, of -4 m M and is exclusively modified on the first Glu in the -Glu-Glusequence. It is striking that y-carboxylated residues in the blood-clotting proteins are clustered near the N-terminus of the protein, but the natural substrates show such a wide variation in local sequence that it has seemed unlikely that local primary or secondary structure in the mature protein could determine specificity completely. cDNA sequencing of several such proteins has indicated that they are biosynthesized as precursors; immediately following the conventional N-terminal cleavable secretory pre-sequence is a prosequence of -18 residues which is not found in the mature protein. Recent site-directed mutagenesis studies on this region indicate that it is this, rather than local sequence around the substrate residue, which constitutes the specificity determinant for y-carboxylation (Jorgensen et al., 19876) .
Some positional influence on modification distinct from local sequence is also evident in analyses of the pattern of Nglycosyl side-chains. N-Glycosylation is initiated by transfer of a preformed oligosaccharide from a dolichol carrier to the nascent or newly synthesized polypeptide within the ER. Before exit from the GR, terminal glucose residues are trimmed off to leave a 'high-mannose' structure. Subsequent processing of this by various enzymes located within the Golgi can lead to the production of a wide variety of 'complex' oligosaccharide moieties. No obvious rules have emerged for determining whether a specific potential Nglycosylation site will be glycosylated and, if glycosylated, whether it will be modified to a complex structure. However, a statistical analysis of over 50 proteins where the state and sites of glycosylation were fully defined showed that 'complex'-type oligosaccharide groups predominate in the Nterminal regions of proteins, whereas a clear majority of 'high-mannose' groups were found on residues more than 200 residues from the N-terminus (Pollack & Atkinson, 1983) .
The complexity of the problem of determining the basis of modification specificity is indicated by analysis of N-terminal acetylation (Augen & Wold, 1986 ). This process is cotranslational, occurring when the nascent chain is 20-50 residues in length. N-Acetylated proteins show a bias towards Ser and Ala at the N-terminus, but many proteins with these Ntermini are not acylated. When pattern-recognition methods were used to compare the N-terminal 40 residues in acetylated and non-acetylated proteins with N-terminal Ser and Ala, three regions were identified as significant (residues I -10, 16-24, and 30-36), but no specific physical or conformational properties of these regions could be discerned. On the one hand, it is tempting to argue that some conformational feature( s) must be the specificity determinants in this and other modifications, but on the other, there is little ground for believing that short nascent polypeptides have well-defined conformations.
Whether a protein undergoes a specific post-translational modification, is determined by properties of the cell in which it is expressed, as well as by features intrinsic to the protein itself. Thus filamentous fungi 0-glycosylate their secretory hydrolases on Ser and Thr residues, but do not carry out extensive N-glycosylation; when these proteins are expressed in yeast from cloned genes, the products show N-glycosylation characteristic of yeast proteins (Yoshizumi & Ashikari, 1987) . Analogously, influenza virus haemagglutinins show marked differences in glycosylation pattern depending on the host cells in which the virus is cultured (Deom & Schulze, 1985) .
This host-specificity of post-translational modification is a significant concern for the production of therapeutic proteins by recombinant DNA methods, since considerable background work is necessary first to establish whether fully authentic modification is essential to the activity and stability of the product and then to establish which host system will produce authentic modification (Bialy, 1987) . Although yeast can N-glycosylate, the oligosaccharide side-chain structures ultimately produced are generally polymannans, different from those characteristic of mammalian cells. Even in mammalian cells, authentic modification may be a function of the rate at which the recombinant protein is expressed; the extent of y-carboxylation of recombinant prothrombin and Factor IX secreted from CHO cells is significantly decreased when the cloned gene is highly amplified, suggesting that the carboxylase is limiting and may be saturated by high levels of expression of its substrate (Jorgensen et al., l987a, h) .
Interdependence of p~st-translational modifications. folding and transport
The difficulty in defining simple determinants for specificity of modification raises questions concerning the temporal, spatial and causal relationships between various modifications. In proteins subject to multiple different modifications, does one modification specify another? This is evidently the case for the sequential processing steps on Nglycosyl side-chains, but otherwise there is little evidence for this. For example, in procollagen, hydroxylation of Pro residues in the central collageneous domain occurs on nascent chains, whereas interchain disulphides between Cys residues in the C-terminal domains are necessarily formed later, immediately after termination. If hydroxylation is inhibited, the complete, but unhydroxylated, chains still trimerize through interchain disulphides, but do not fold into the triple-helical conformation. Hence neither modification is a prerequisite for the other. However, where modification processes are spatially separated in the cell, an earlier modification may indirectly be a prerequisite for a later modification through its influence on the protein's progress along the secretory pathway. This raises complex questions about the relationship between modification, folding and transport.
Are spec@ modifications required for transport and targeting or vice-versa? There is one well-defined system, targeting to the lysosome, in which specific post-translational modification generates the crucial targeting signal (von Figura & Hasilik, 1986) . Lysosomal proteins are initially secreted on membrane-bound ribosomes and are transferred to the E R lumen and Golgi by the pathway and mechanism followed by secretory proteins, including N-glycosylation and oligosaccharide side-chain processing to high-mannose derivatives. Within the Golgi, proteins destined for the lysosome are specifically marked by the successive addition of Nacetylglucosamine phosphate and removal of N-acetylglucosamine to leave terminal mannose-6-phosphate groups; these interact with a specific receptor in the Golgi which effects transfer to lysosomes. The initial transferase is highly specific, since high-mannose groups on secretory proteins, or on denatured lysosomal precursors, or the free highmannose oligosaccharide, are poor substrates; it must therefore recognize some denaturable conformational element common to all lysosomal precursor proteins which is distinct from the oligosaccharide acceptor. The nature of this determinant is unknown and is not readily apparent from comparison of primary sequences of lysosomal enzymes.
For non-lysosomal proteins, the relationship between modification and transport along the secretory pathway is more obscure. Since most secretory proteins are glycosylated, it was argued for many years that glycosylation might target proteins for secretion. However, no obligatory link between glycosylation and secretion could be established, and so any apparent linkage between glycosylation and secretion in specific proteins must require subtler explanations. Blockage of glycosylation at the earliest stage by tunicamycin inhibits Ig secretion, but not that of very many other secretory proteins. The effects of tunicamycin on the transfer to the plasma membrane of vesicular stomatitis virus envelope G protein and the production of active virions varies markedly with the viral strain and the temperature of incubation of the host cells (Sabatini et a[., 1982) . Similarly variable effects are noted when the ER glycosidases are inhibited by 1-deoxynojirimycin. Thus glycosylation is not itself required for transport, but may affect some other property required for transport, such as the conformation of solubility of the modified protein.
As with the glycosylation, so other post-translational modifications characteristic of secretory proteins are not directly required for secretion, and many un-or mis-modified proteins pass satisfactorily through the secretory pathway. For example, in vitamin K-deficient or warfarin-treated animals, y-carboxylation is drastically inhibited, but noncarboxylated and inactive forms of prothrombin and other clotting factors are found in the serum. Hence modification is not a prerequisite for secretion.
Conversely, where enzymes catalysing successive posttranslational modifications are located at different points in the secretory pathway, movement along the pathway is a prerequisite for sequential modifications, and this can be used as a valuable tool for exploring the details of the secretory process. Thus transfer of secretory protein precursors from ER to Golgi vesicles in vitro has been reconstituted using the appearance of Golgi-specific modifications as the assay for transfer. Both yeast (Haselbeck & Schekman, 1986) and animal cell (Balch et al., 1987) systems have been established; the donor systems comprise vesicles in which the subVOl. 17 BIOCHEMICAL SOCIETY TRANSACTIONS strate protein is present within E R vesicles in precursor form because of a mutation which blocks either transfer to the Golgi or a Golgi-specific processing step; the acceptor systems are comparable vesicles from cells in which the substrate protein is not synthesized, but where the Golgi is competent in carrying out a detectable Golgi-specific processing step. With these assay systems a dependence on ATP and cystosolic factors for transport from ER to Golgi has been demonstrated.
Are specific modifications required for folding o r vice versa? Although the mechanism is not well defined, nascent secretory polypeptides are generally inferred to be in a flexible, unfolded conformation as they pass across the E R membrane (Maher & Singer, 1986; Eilers & Schatz, 1988) , so that initial N-glycosylation, Lys-and Pro-hydroxylation and y-carboxylation occur on essentially unfolded nascent chains. Cotranslational folding may occur (Tsou, 1988) , but generation of a defined stable folded conformation probably requires the emergence of a completed domain into the extracytoplasmic environment.
Both in eukaryotes and in bacteria (e.g. Pollitt & Zalkin, 198 1 ), the formation of native disulphide bonds occurs at this point, and thereupon restricts the mobility of the newly synthesized protein (Wetzel, 1987 ). This stable folding may limit the extent of N-glycosylation, y-carboxylation or hydroxylation, although the newly folded proteins are still in the same compartment as the enzymes responsible for those modifications.
Conversely, the modifications incorporated in the unfolded nascent chain may influence the folded conformation which is achieved, as in the case of procollagen noted above, where hydroxylation is required for formation of a stable triple helix.
Can modifications affect transport through an influence on folding? The possibility that modifications can, in some cases, alter the conformational and solubility properties of newly synthesized proteins may explain the indirect relationship noted above between modification and secretion, which appeared to depend on protein, temperature and other variables. There is now a good body of evidence suggesting that incorrect folding in the ER may inhibit transfer of proteins further along the secretory pathway. Thus a mutant human a-antitrypsin is correctly processed and glycosylated, but remains within the ER probably because the mutation breaks a crucial salt-bridge which stabilizes the protein's natural conformation (Verbanac & Heath, 1986) . Similarly, mutant influenza haemagglutinins which do not exit the ER can be shown to have failed to fold and to form native trimeric species (Gething et al., 1986) .
Thus it is possible to interpret the cases noted above where inhibition of glycosylation blocks exit from the ER, as indirect effects arising from altered conformational properties of the incorrectly modified proteins. Similarly, the formation of some disulphide bonds may be a prerequisite for correct folding and hence for transfer to the Golgi; a mutant of human lysozyme with Cys-Ala mutations at Cys-77 and Cys-95 was expressed at high levels in yeast, but retained within the ER, whereas the wild-type was efficiently secreted (Taniyama et al., 1988) .
These complex relationships between modification, folding and intracellular movement are exemplified by studies on the development of ligand-binding activity in newly synthesized insulin-and epidermal growth factor-receptors (Slieker et al., 1986; Olson & Lane, 1987) . In both cases, the acquisition of ligand-binding activity follows core N-glycosylation in the ER, but precedes processing events known to occur in the Golgi. Unglycosylated nascent receptor synthesized in presence of tunicamycin does not develop mature binding activity, but N-glycosylation is not intrinsically required for binding activity since deglycosylation of the mature receptors does not abolish activity. The half-time for maturation corresponds to that for exit from the ER and for the acquisition of conformational features recognized by specific antibodies. Thus ligand-binding activity appears to be correlated with conformational changes which require a prior post-translational modification, but are not thereafter dependent on that modification.
Conclusion
Together with folding, and related processes, post-translational modifications present a currently unsolved problem in the interpretation of genetic information. While an mRNA or cDNA sequence can be reliably translated into polypeptide sequence by application of known coding rules, the subsequent post-translational modifications of this polypeptide cannot be predicted with any confidence. This uncertainty arises from our poor understanding of the basis of specificity in the post-translational modification of newly synthesized secretory proteins, and from the fact that the complement of enzymes catalysing post-translational modifications varies from cell to cell and from species to species; this contrasts with the (almost) universality and predictability of the code for translation of mRNA to polypeptide sequence. The rapid advances of recombinant DNA technology have now made it possible to obtain primary polypeptide sequences of proteins which have never been isolated in pure form, and to express in heterologous cells recombinant proteins which have never before been available in quantity. Our inability to predict post-translational modification reliably, and hence to define completely the authentic covalent structure of these proteins when expressed in their cells of origin, is a major obstacle to our understanding and exploitation of the numerous new proteins now being defined.
